Amol Soin, MD
Interventional Pain Medicine · Dayton, OHNPI 1316135585
Payments from drug & device makers
Across 412 payments — averaging $445.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Avanos Medical$172K
- Vertos Medical, Inc.$2K
- Abbott$2K
- Boston Scientific$1K
- Nevro Corp.$813
- Teva Pharmaceuticals USA, Inc.$548
- plus $5K from 25 others
Across 1 payment — averaging $16.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Saluda Medical Americas, Inc.$16
What the payments were for
- Consulting fees$1,0006%
- Speaking & faculty fees$4,10023%
- Travel & lodging$1521%
- Food & beverage$12,40870%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Avanos Medical | 40 | $171,877 |
| Vertos Medical, Inc. | 33 | $2,211 |
| Abbott | 30 | $2,099 |
| Boston Scientific | 19 | $1,279 |
| Nevro Corp. | 15 | $813 |
| Teva Pharmaceuticals USA, Inc. | 61 | $548 |
| AbbVie(2 entities) | 38 | $527 |
| Lilly USA, LLC | 36 | $432 |
| Amgen | 21 | $415 |
| Globus Medical | 4 | $387 |
| Saluda Medical Americas, Inc. | 7 | $372 |
| Medtronic(3 entities) | 8 | $343 |
| Pfizer | 44 | $295 |
| Stryker | 4 | $287 |
| Stimwave Technologies Incorporated | 3 | $281 |
| GRT US Holding, Inc. | 5 | $244 |
| Curonix LLC | 2 | $227 |
| Biohaven Pharmaceuticals, Inc. | 11 | $191 |
| Biotronik NRO, Inc. | 3 | $179 |
| Painteq LLC | 6 | $146 |
| Novartis | 6 | $102 |
| Nalu Medical, Inc. | 1 | $94 |
| Vertex | 3 | $71 |
| IBSA Pharma Inc. | 3 | $53 |
| SPR Therapeutics, Inc | 1 | $44 |
| Si-bone, Inc. | 3 | $40 |
| MDD US Operations, LLC | 1 | $20 |
| Tonix Medicines, Inc. | 1 | $17 |
| Scilex Pharmaceuticals Inc. | 1 | $16 |
| Assertio Therapeutics, Inc. | 1 | $13 |
| Zyla Life Sciences, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- COOLIEF$2,800
- ON-Q$2,300
- mild Device Kit$1,611
- PROCLAIM$871
- Senza Spinal Cord Stimulation System$423
- StimQ Receiver Stimulator Kit Channel A US w Receiver$378
- StimQ Freedom-4A Receiver Kit Channel A US w/ Receiver$378
- StimQ Freedom 8A Receiver Kit Channel A US w Receiver$378
- Freedom 4A Receiver Kit Channel A US w Receiver$378
- Freedom 8A Receiver Kit Channel A US w Receiver$378
- Senza$357
- Proclaim Family of SCS IPGs$289
- Evoke$245
- Proclaim IPG$181
- Qutenza$174
- COOLIEF* COOLED RADIOFREQUENCY$148
- CLINICAL TRIAL PRODUCT$144
- GENERAL PAIN MANAGEMENT$130
- Superion Indirect Decompression System$129
- SPECTRA WAVEWRITER$125
How this compares
$183,634 in reported general payments places this provider in the 95th percentile of 67 interventional pain medicine providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lidocaine | 26 | $3,101 |
| Tizanidine Hcl | 86 | $855 |
| Nabumetone | 64 | $666 |
| Diclofenac Sodium | 28 | $570 |
| Cephalexin | 77 | $506 |
| Methocarbamol | 26 | $431 |
| Amitriptyline Hcl | 26 | $331 |
| Etodolac | 12 | $323 |
| Gabapentin | 30 | $260 |
| Methylprednisolone | 40 | $251 |
| Ciprofloxacin Hcl | 35 | $161 |
| Duloxetine Hcl | 21 | $145 |
| Cyclobenzaprine Hcl | 14 | $118 |
| Meloxicam | 35 | $78 |
| Ibuprofen | 12 | $73 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Dayton
- Gladstone McDowellColumbus$701K
- Sara NashiCincinnati$140K
- Humam AkbikFairfield$117K
- Jaudat MahmoodKent$97K
- David WalegaColumbus$75K
- Jayesh VallabhColumbus$73K
- Omar AliSpringfield$67K
- Dustin ReynoldsWesterville$62K
- Mark MalinowskiChillicothe$57K
- Daniel VerrillKettering$49K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.